The Broad Institute’s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of ...

The National Academies of Sciences, Engineering, and Medicine's National Cancer Policy Forum convened this workshop in collaboration with the Roundtable on Genomics and Precision Health. The virtual, ...

AWS Social Impact and Sustainability Program awards Admera Health, Bringing Next-Generation Genomics to Underserved ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.

Hayley Knollman, MD, explains how ctDNA and genomic testing impact ER-positive metastatic breast cancer care, guiding ...

Precision medicine enabled by genetic and molecular profiling advances helps scientists and clinicians more easily tailor diagnostics and treatments for a range of conditions. Researchers increasingly ...

Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PharosAI brings together King's College London, ...

Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next ...

A study from Columbia University Mailman School of Public Health reports a major advance in understanding how interactions ...

DNADX high scores predicted improved PFS, supporting genomic instability and DNA repair deficiency as biologically relevant ...